Prof. Xiaoping Ren | Spinal Cord Injury Repair | Best Researcher Award
Archiater at Ruikang Hospital, China
Dr. Xiaoping Ren is a distinguished academician affiliated with the Russian Academy of Natural Sciences and the American Academy of International Surgery. He is the Director of Orthopedics and the Orthopedic Research Institute at Ruikang Hospital, Guangxi University of Chinese Medicine. His extensive professional experience includes serving at prestigious institutions such as the University of Louisville, University of Cincinnati, and University of Colorado at Chicago. Dr. Ren’s primary research interest lies in functional reconstruction after spinal cord injury, where he has pioneered the spinal cord fusion theory (GEMINI PROTOCOL) and the use of spinal cord fusion agents (PEG Cocktails). He has published over 70 SCI papers and holds numerous patents. His accolades include the Yingwei Award, United Nations Goodwill Ambassador for Health and Medical Development, and recognition as one of the 12 life-prolonging breakthroughs by X-Prize. 🌟👨⚕️🔬
🎓 Education
Dr. Xiaoping Ren’s educational journey began at Harbin Medical University in China, where he earned his undergraduate degree in Medicine. He continued his studies at the same university, obtaining a Master’s degree in Orthopedics and a Ph.D. in Orthopedic Surgery. Seeking to broaden his expertise, Dr. Ren pursued postdoctoral training at the University of Louisville in the United States, specializing in orthopedic surgery and research. His quest for advanced knowledge led him to the University of Cincinnati, where he furthered his training in advanced orthopedic research. This extensive and diverse educational background has equipped Dr. Ren with a deep understanding of both clinical and research aspects of orthopedics, enabling him to make significant contributions to the field, particularly in spinal cord injury and functional reconstruction. 🌍🔬📘
Professional Experience
Dr. Xiaoping Ren has an extensive professional background in both clinical practice and academic research. Currently, he serves as the Director of the Department of Orthopedics and the Orthopedic Research Institute at Ruikang Hospital, Guangxi University of Chinese Medicine (2019-present). His previous appointments include positions at the University of Louisville (1996-2000), University of Cincinnati (2001-2014), and the School of Medicine at the University of Colorado at Chicago (2014-2018). In China, he has worked at Harbin Medical University and other institutions, where he held roles as a professor of orthopedics, chief physician, and doctoral supervisor (2012-2018). Dr. Ren is recognized as a Vebleo Fellow and is a member of the American Society of Hand Surgery and the American Society of Bone Surgery and Neurology. His work spans significant contributions to orthopedic surgery, including pioneering clinical models and international studies in the field. 🏥📚
Research Interest
Dr. Xiaoping Ren’s research interests focus on functional reconstruction and regeneration following spinal cord injuries. Over the past 30 years, he has published more than 70 SCI papers with a cumulative impact factor of 500. His current research revolves around the spinal cord fusion theory (GEMINI PROTOCOL), which involves using spinal cord fusion agents (PEG Cocktails) for functional recovery after spinal cord injury. This innovative approach was first validated by Dr. Ren’s team through preclinical animal experiments and clinical transformation studies, gaining international acclaim. His pioneering work has not only advanced the understanding of spinal cord injuries but also positioned China at the forefront of this medical research field. In addition to his research, Dr. Ren has edited two English monographs, contributed to a third, and secured numerous patents for his inventions both in China and abroad. 📚🔬🧠
Award and Honors
Dr. Xiaoping Ren has received numerous awards and honors throughout his distinguished career. In 2022, he won the third prize for scientific and technological progress from the Society of Integrated Chinese and Western Medicine and was recognized as one of the first batch of warehousing experts from the China Science and Technology think tank. He was awarded the second prize for scientific and technological progress in Guangxi in 2021, the Yingwei Award at the Second International Academician Congress in 2021, and the honorary title of United Nations Goodwill Ambassador for Health and Medical Development in the Asia-Pacific Region in 2021. Additionally, he was honored as a doctor/advisor of the Hainan Provincial Association for the Promotion of Academician Industry in 2021 and deputy director of the productivity research institute of the Chinese Academy of Management in 2021. Dr. Ren is a member of the Russian Academy of Natural Sciences (2020) and the American Academy of International Surgery (2016). His work on the AHBR model was selected as one of the 12 life-prolonging breakthroughs by X-Prize in 2019 and one of the ten most attractive innovative technologies by MIT’s Technology Review in 2017. 🏅🎖️🌟
Research Skills
Dr. Xiaoping Ren possesses a wide array of research skills that have significantly contributed to his field. His expertise includes designing and implementing clinical models, such as the world’s first clinical model of CTA and the first American hand allotransplantation. He has a deep understanding of international RPCT and RCI phenomena, and has designed and completed groundbreaking procedures like the world’s first mouse head transplantation and the first human AHBR surgical model. Dr. Ren is highly skilled in spinal cord fusion research, focusing on functional recovery and regeneration after spinal cord injury. His work with spinal cord fusion agents (PEG Cocktails) has been internationally recognized. Additionally, he has published over 70 SCI papers, edited two English monographs, and holds numerous patents both in China and abroad. Dr. Ren’s research skills encompass both preclinical animal experiments and clinical transformation experiments, making him a leader in medical frontier research. 🧬🔬📚
Publications
- Developing preclinical dog models for reconstructive severed spinal cord continuity via spinal cord fusion technique
- Authors: Shen, T., Zhang, W., Lan, R., Cao, Z., Ren, X.
- Year: 2024
- Journal: IBRO Neuroscience Reports
- Application of “Spinal cord fusion” in spinal cord injury repair and its neurological mechanism
- Authors: Shen, T., Zhang, W., Wang, X., Ren, X.
- Year: 2024
- Journal: Heliyon
- Effect of vascularized lymph node transplantation combined with lymphatico-venous anastomosis in the treatment of lymphedema after breast cancer surgery
- Authors: Lan, R., Zhang, W., Han, L., Qin, J., Ren, X.
- Year: 2023
- Journal: Chinese Journal of Plastic Surgery
- Microsurgical thinned anterolateral thigh perforator flap to repair soft tissue defects of foot and ankle
- Authors: Lan, R.-Y., Jiang, J.-Y., Yu, T., Han, L.-X., Ren, X.-P.
- Year: 2023
- Journal: Zhongguo gu shang = China Journal of Orthopaedics and Traumatology
- Partial restoration of spinal cord neural continuity via vascular pedicle hemisected spinal cord transplantation using spinal cord fusion technique
- Authors: Ren, X., Zhang, W., Qin, J., Wei, L., Ren, S.
- Year: 2022
- Journal: CNS Neuroscience and Therapeutics
- Partial Restoration of Spinal Cord Neural Continuity via Sural Nerve Transplantation Using a Technique of Spinal Cord Fusion
- Authors: Ren, X., Zhang, W., Mo, J., Wang, X., Ren, S.
- Year: 2022
- Journal: Frontiers in Neuroscience
- GEMINI-supported spinal cord transplantation for the treatment of chronic spinal paralysis: Overview and initial clinical translation
- Authors: Ren, X.P., Henderson, P., Kim, C.Y., Canavero, S.
- Year: 2022
- Book Chapter: Diagnosis and Treatment of Spinal Cord Injury
- LncRNA DARS-AS1 Promoted Osteosarcoma Progression through Regulating miR-532-3p/CCR7
- Authors: Xue, Y., Liu, H., Nie, G., Ren, X.
- Year: 2022
- Journal: Disease Markers
- Transplantation of a vascularized pedicle of hemisected spinal cord to establish spinal cord continuity after removal of a segment of the thoracic spinal cord: A proof-of-principle study in dogs
- Authors: Ren, S., Zhang, W., Liu, H., Liu, J., Ren, X.
- Year: 2021
- Journal: CNS Neuroscience and Therapeutics
- BAPTA, a calcium chelator, neuroprotects injured neurons in vitro and promotes motor recovery after spinal cord transection in vivo
- Authors: Kang, K.-R., Kim, J., Ryu, B., Kim, C.-Y., Chung, H.M.
- Year: 2021
- Journal: CNS Neuroscience and Therapeutics